Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

Hepatology

Volumn 39, Issue 6, 2004, Pages 1647-1654

  Dixon, John B ^a   Bhathal, Prithi S ^b   Hughes, Norman R ^b   O'Brien, Paul E ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRIC BANDING; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; SCORING SYSTEM; STEATOSIS; WEIGHT REDUCTION;

ADULT; FATTY LIVER; FEMALE; HUMANS; MALE; WEIGHT LOSS;

EID: 2542546652     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20251     Document Type: Article

References (34)

1. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
2. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122:1649-1657.
3. Park HS, Kim MW, Shin ES. Effect of weight control on hepatic abnormalities in obese patients with fatty liver. J Korean Med Sci 1995;10:414-421.
4. Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991;12:224-229.
5. Drenick EJ, Simmons F, Murphy JF. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med 1970;282:829-834.
6. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997;27:103-107.
7. DeWind LT, Payne JH. Intestinal bypass surgery for morbid obesity. Long-term results. JAMA 1976;236:2298-2301.
8. O'Leary JP. Hepatic complications of jejunoileal bypass. Semin Liver Dis 1983;3:203-215.
9. Fox SR, Fox KS, Ch KH. The gastric bypass for failed bariatric surgical procedures. Obes Surg 1996;6:145-150.
10. Antal SC. Prevention and reversal of liver damage following biliopancreatic diversion for obesity. Obes Surg 1994;4:285-290.
11. Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004;135:48-58.
12. Chapman A, Kiroff G, Game P, Foster B, O'Brien P, Ham J, et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic review. Surgery 2004;135:326-351.
13. Colman P, Thomas D, Zimmet P, Welborne T, Garcia-Webb P, Moore M. New classification and criteria for diagnosis of diabetes mellitus. Med J Australia 1999;170:375-378.
14. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
16. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program [letter]. Diabetes Care 1998;21:2191-2192.
17. Metropolitan Life Foundation. Height and Weight Tables: Metropolitan Life Foundation. New York: Metropolitan Life Insurance Company, 1983.
18. James J, Bosch KS, Zuyderhoudt FM, Houtkooper JM, van Gool J. Histophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver. Histochemistry 1986;85:129-133.
19. Vyberg M, Leth P. Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease. APMIS Suppl 1991;23:46-52.
20. Freedman R, Uwaifo GI, Lutchman G, Promrat K, Kleiner D, Yanovski JA, et al. Changes in insulin sensitivity and improvements in liver histology in patients with non-alcoholic steatohepatitis (NASH) treated with Pioglitozone. Diabetes 2003;52:A76.
21. Lee RG. Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler. HEPATOLOGY 1995;21:1742-1743.
22. Kleiner DE, Brunt EM, Van Natta ML, Behling C, Constos MJ, Cummings OW, et al. Design and validation of a histologic scoring system for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. HEPATOLOGY 2003;38:233A.
23. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. HEPATOLOGY 2003;37: 1202-1219.
24. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
25. O'Brien PE, Dixon JB, Brown W, Schachter LM, Chapman L, Burn AJ, et al. The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg 2002;12:652-660.
26. SPSS Inc. SPSS for Windows, version 10.0.5. Chicago: SPSS. Inc, 1999.
27. National Institutes of Health. Methods for voluntary weight loss and control. NIH Technology Assessment Conference Panel. Consensus Development Conference, 30 March to 1 April 1992. Ann Intern Med 1993;119: 764-770.
28. Luyckx FH, Desaive C, Thiry A, Dewe W, Scheen AJ, Gielen JE, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998;22:222-226.
29. Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. HEPATOLOGY 2003;38:1008-1017.
30. Ong JP, Younossi ZM, Speer C, Olano A, Gramlich T, Boparai N. Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver 2001;21:266-271.
31. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000;32:209-217.
32. Hickman IJ, Clouston AD, Macdonald GA, Purdie DM, Prins JB, Ash S, et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C [comment]. Gut 2002;51:89-94.
33. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. HEPATOLOGY 1999;29:1215-1219.
34. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. HEPATOLOGY 1997;25:108-111.